In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

The timing for the potential tax is yet to be determined, as the industry awaits to see the impact it could bring. The tariffs—if they do take effect—are expected to rise over the next year. The same ...

In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly ...

Many would agree that over the past five years or so, telehealth has skyrocketed in popularity, as another way to provide clinical healthcare, increasing access to mental health and managed care. 1-4 ...

Becton, Dickinson and Company (BD), a medical technology (MedTech) company that produces and sells medical devices, laboratory equipment, and diagnostic products, is voluntarily recalling one lot of ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jim Shehan, chair of the FDA regulatory practice at Lowenstein Sandler, explains how he anticipates the evolving ...